🔗 Share this article

Grammy-winning R&B singer D’Angelo passed away on October 14 at age 51 after a private battle with pancreatic cancer.

“The brilliant light of our family has faded away for us in the present world,” his family confirmed. “After a lengthy and brave battle with the disease, we are deeply saddened to announce that D’Angelo, recognized by his followers around the world as D’Angelo, has been called home.”

D’Angelo made a lasting impact on music with his innovative neo-soul sound and collaborations with renowned musicians.

He released his debut album, “Brown Sugar,” in the mid-nineties to instant praise. The album achieved No. 4 on Billboard’s Top R&B Albums chart, went platinum soon after, and earned several award nominations.

However, it was his second album, “Voodoo,” in the year 2000 that boosted his music career into the stratosphere. The album premiered at the top spot on both Billboard’s Top R&B Albums chart and the Billboard 200. He received two Grammy Awards: Top R&B Record and Best Male R&B Vocal Performance for “Untitled (How Does It Feel).”

The music video for “Untitled (How Does It Feel)” cemented D’Angelo’s standing as a icon, albeit a reluctant one, in the public consciousness. The intimate portrayal featured the artist, notably bare to his midsection, singing directly into the lens.

D’Angelo retreated from the spotlight after releasing Voodoo and openly battled with substance abuse. In 2005, he was part of a severe car crash that left him in grave health.

Over ten years later, his third and final album, “Black Messiah” (2014), confirmed his enduring appeal with a further top chart entry on the soul music rankings and a award for Top R&B Record.

Once more, in his own mysterious way, D’Angelo had limited public appearances in the following years.

The musician was scheduled as a top act for the 2025 music event, but his appearance was called off, due to an “unforeseen medical delay.”

Even though information is limited about D’Angelo’s health in the months leading up to his death, he had reportedly been hospitalized for an extended period and in palliative care for two weeks.

D’Angelo’s demise is a clear example of the harmful impact of pancreatic malignancy, one of the most deadly and hardest to prevent forms of the illness, on a brilliant talent whose life was cut short.

“We are grieved that he can only leave cherished moments with his loved ones, but we are eternally grateful for the heritage of deeply emotional music he leaves behind,” his family said.

Pancreatic Malignancy: Deadly and Difficult to Avoid

Pancreatic cancer affects the digestive organ, a small organ that produces the hormone insulin and is vital in breaking down food, among other functions. The position and dimensions of the organ in the human system make it more difficult to detect cancer.

Even though this cancer accounts for only about 3% of cancer diagnoses each year in the United States, it is causes 7% of cancer deaths.

Nearly 70,000 people will be diagnosed with this condition and about 52,000 will succumb to the illness in 2025.

“This malignancy is one of the most lethal diseases, with an fast-growing mass and poor prognosis. We have few and poor therapies, and a smaller window to make a significant difference on the lives of people,” noted a cancer specialist.

Because pancreatic cancer rarely causes early symptoms, it’s often identified only after the condition is advanced. Even when a patient has indicators they are usually vague and may be mistaken for a number of everyday ailments.

“As of yet, there is no effective method to detect pancreatic cancer in the early stages, except for paying attention to physical changes and speaking with your doctor if there are new or unusual signs,” explained a health expert.

Common symptoms of pancreatic cancer include:

• discomfort in the stomach or back
• weight loss
• jaundice
• loss of appetite
• brownish urine
• pale or fatty bowel movements
• loose stools
• excessive hunger or thirst
• feeling sick

At age 51, D’Angelo’s death is an exception, as pancreatic cancer is typically found in individuals in the 65 to 75 range. However, numerous malignancies, including pancreatic cancer, have become more common in younger adults.

“Pancreatic cancer diagnosed before the age of 50 is deemed uncommon, yet concerningly, clinicians are beginning to see a growing number of younger patients affected by this condition,” said a specialist.

Genetic Background Affects Cancer Risk

Without effective detection methods for this malignancy, experts stressed the significance of understanding your family’s cancer history. Some risk factors, such as smoking and excess weight also play a role in the development of pancreatic cancer.

Black individuals have the highest incidence of this malignancy in the United States and are more prone to be found to have untreatable disease.

“The first step toward lowering one’s risk of this condition is assessing personal risk factors. People should review their genetic background, hereditary factors, and medical conditions, such as blood sugar disease, chronic pancreatitis, or obesity that may raise their vulnerability,” said a specialist.

Hereditary elements are associated with as much as ten percent of all pancreatic cancer cases. If a relative in your household has had this disease, you may want to consider DNA analysis.

“For people with a family history of pancreatic cancer or those having high risk genetic mutations, checking may involve sophisticated scans such as magnetic resonance imaging (MRI) or internal ultrasound to detect initial alterations in the organ,” he explained.

For those looking to reduce their risk, lifestyle changes may make a difference. The most effective action you can take to reduce your susceptibility of pancreatic cancer is to quit smoking, and if you don’t smoke, stay away altogether.

Heavy alcohol consumption is associated with pancreatitis, a risk factor for this malignancy, so limiting or avoiding drinks may help reduce your risk.

Controlling your body mass or shedding pounds may also help decrease your susceptibility. Individuals with obesity are twenty percent more prone to get this disease. Pancreatic cancer also occurs more often in people with blood sugar issues, and reducing weight can also reduce the risk of type 2 diabetes.

In spite of pancreatic cancer’s poor prognosis, there is still hope.

“We are making progress with therapies and newer combination chemotherapy. There are developing targeted therapies that already are making an impact,” remarked a specialist.

For many people, however, education about this uncommon but {dev